Abstract
Intellectual property biotechnology, with special emphasis on biotech patents, is considered a strong tool in the development of biotechnological R&D and biotech industry. In the European patent system, more than 50% of the granted biotech patents cover pharmaceutical products, around 40% refer to industrial processes in biotechnology, and the rest are patents granted for application of biotechnology in agriculture and environmental protection.
The authors propose to reveal specific insights into patenting biotechnological inventions, according to the European Patent System, emphasizing what can be protected or not protected by patents in the area of biotechnology, considering the legislation in force in this field, and ethical and moral disputes on this subject.
The authors give special attention to aspects regarding the transfer of innovation in biotechnology, referring to its very specific problems and how intellectual property could interfere with facilitating this transfer of knowledge.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BoA:
-
Board of appeal
- EBoA:
-
Enlarged board of appeal
- EC:
-
European Commission
- EPC:
-
European Patent Convention
- EPO:
-
European Patent Office
- EU :
-
European Union
- G :
-
Decision of the EBoA
- GL:
-
Guidelines for examination under the European Patent Convention
- IP:
-
Intellectual property
- IPR:
-
Intellectual property right
- OECD:
-
Organization for Economic Cooperation and Development
- SPC :
-
Supplementary protection certificate
- T:
-
Decision of the technical board of appeal
- UPOV:
-
Union pour la Protection des Obtentions Vegetales
- WIPO:
-
World Intellectual Property Organization
References
Arundel A (2003) Biotechnology indicators and public policy. STI Working Papers. OECD, Paris
Blatmann A, Heuzenroeder P, O’Brien M (2008) Biotechnology intellectual property management manual. Spruson & Ferguson, pp 8–14
Burrone E (2006) Patents at the core: the biotech business. https://www.wipo.int/
DaSilva JE (2004) The colours of biotechnology: science, development and humankind. Electron J Biotechnol 7(3)
Directive 98/44/EC (1998) Directive of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions, published in Official Journal of the European Communities, 30 July 1998, extracted from https://eur-lex.europa.eu
Dutfield G (2009) Intellectual property rights and the life science industries – past, present and future, 2nd edn. World Scientific, Singapore, pp 204–205
EC (2002) Life sciences and biotechnology – a strategy for Europe
EPC (2016a) European Patent Convention 2000, 16th edn, Chapter V, Rule 26, Biotechnological inventions, published on June 2016 on https://www.epo.org/law-practice/legal-texts/epc.html
EPC (2016b) European Patent Convention 2000, 16th edn, Art. 64 (1), (3), published on June 2016 on https://www.epo.org/law-practice/legal-texts/epc.html
EPC (2016c) European Patent Convention 2000, 16th edn, Art. 52–53, published on June 2016 on https://www.epo.org/law-practice/legal-texts/epc.html
EPC (2016d) European Patent Convention 2000, 16th edn, Rule 29, published on June 2016 on https://www.epo.org/law-practice/legal-texts/epc.html
EPC (2016e) European Patent Convention 2000, 16th edn, Art. 54(4) and (5), published on June 2016 on https://www.epo.org/law-practice/legal-texts/epc.html
EPO (2009) Decision of the enlarged board of appeal G2/06, dated 25 November 2008, published in the Official Journal of the EPO 5/2009, p 306
EPO (2012) Decisions of the enlarged board of appeal G2/07 and G1/08, dated 09.12.2010, published in the Official Journal of the EPO 3/2012, p 130, 206
EPO (2016) Decisions of the enlarged board of appeal G2/12 and G2/13, dated 25 March 2015, published in the Official Journal of the EPO 2016, A27, A28
EPO (2017a) Biotechnology patents at the EPO, extracted from http://www.epo.org/news/issues/biotechnology-patents, last updated on 16 January 2017
EPO (2017b) Decision of the Administrative Council of 29 June 2017 amending rules 27 and 28 of the implementing regulations to the European Patent Convention (CA/D 6/17), Official Journal of the EPO, A56
EPO (2017c) Is it in my genes? The future of personalised medicine is focused on individual patient DNA, last updated on 24 May 2017, from https://www.epo.org/news-issues/technology/medical-technologies/personalised-medicine
EPO (2017d) Using red algae to fight the flu, EPO SME case studies/MARINOMED, published on www.epo.org/sme
EPO (2018a) Annual report 2017 – European patent applications, published on 22 January 2018 on https://www.epo.org/
EPO (2018b) Decision of the opposition division of the EPO published in the European Patent Bulletin 8/44 of 29 October 2018
EPO (2018c) Annual report 2017 – At a glance, published on 22 January 2018, www.epo.org/statics-indicators2017
EPO (2019) Decisions of the technical board of appeal T1063/18, issued on 05 February 2019, extracted from http://www.epo.org/law-practice/case-law-appeals/communications
EU Commission (2016) Notice on certain articles of Directive 98/44/EC of the European Parliament and of the Council on the legal protection of biotechnological inventions, (2016/C 411/03). Off J Eur Union, C411/3, 08 November 2016
EU Commission (2019) Protection of biotechnological inventions, extracted from http://ec.europa.eu/growt/industry/intelectual-property/patents. Accessed January 2019
Gelinas P (2010) Mapping early patents on baker’s yeast manufacture. Compr Rev Food Sci Food Saf 9:483–497
Guidelines for Examination (2018) GII-35. https://www.epo.org/law-practice/legal-texts
McNamara K, Booth M (2018) The birth of biotech, extracted from www.vennershipley.co.uk
OECD (2002) Genetic inventions, IPRs and Licensing Practices
OECD (2004) Patents and innovation: trends and policy challenges
OECD (2005) A framework for biotechnology statistics. OECD, Paris
Ovlisen M (2002) In Medicon valley patent guide. http://www.mva.org/media
Saez C (2017) Patentability of some biotech uncertain in Europe as examination, opposition suspended. Intellectual Property Watch. http://www.ip-watch.org
Singh KK (2015) Biotechnology and intellectual property rights – legal and social implications. Springer India, pp 66–67
Strenc AC, Ionescu B, Gheorghiu G (2005) Dreptul Brevetului. Editura Lumina Lex, Bucuresti, pp 55–56
Venter C, Cohen D (2004) The century of biology. N Perspect Q 21(4):73–77
WIPO Convention (1967) Convention establishing the world intellectual property organization, Art 2(vii)
Zekos GI (2006) Nanotechnology and biotechnology patents. Int J Law Inform Technol 14:310
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Popa, C., Babeanu, N.E., Popa, O. (2019). Intellectual Property and Transfer of Innovation in Biotechnology. In: Matei, F., Zirra, D. (eds) Introduction to Biotech Entrepreneurship: From Idea to Business. Springer, Cham. https://doi.org/10.1007/978-3-030-22141-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-22141-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22140-9
Online ISBN: 978-3-030-22141-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)